Why are so many Australians taking antidepressants?

by Jon Jureidini,The ConversationCredit: Pixabay/CC0 Public DomainAroundone in seven Australianstake antidepressants; more than3.5 millionof us had them dispensed in 2021

Updated on: May 07,2024

Why are so many Australians taking antidepressants?

by Jon Jureidini,The ConversationCredit: Pixabay/CC0 Public DomainAroundone in seven Australianstake antidepressants; more than3.5 millionof us had them dispensed in 2021

Updated on:May 07,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed

Updated on: July 02,2024

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed

Updated on:July 02,2024

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on: January 30,2024

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on:January 30,2024

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on: May 05,2024

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on:May 05,2024

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

Updated on: July 08,2024

A feasibility study for salvage radiation therapy in prostate cancer

by Impact Journals LLCCredit: CC0 Public DomainAn editorial paper waspublishedinOncoscienceon May 20, 2024, titled, "Deep learning-assisted lesion segmentation in PET/CT i

Updated on:July 08,2024

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on: May 26,2024

Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy

by Weill Cornell Medical CollegeMycobacterium tuberculosis. Credit: United States Centers for Disease Control and PreventionPatients who have drug-resistant tuberculosis (TB) have a similar micro

Updated on:May 26,2024

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on: December 22,2023

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on:December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on: December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on:December 22,2023

Liver cancer study encourages caution with certain gene therapies

bySanford Burnham Prebys Medical Discovery InstituteGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.10.004Research led by Randal J. Kaufman, Ph.D., has

Updated on: December 22,2023

Liver cancer study encourages caution with certain gene therapies

bySanford Burnham Prebys Medical Discovery InstituteGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.10.004Research led by Randal J. Kaufman, Ph.D., has

Updated on:December 22,2023

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on: December 23,2023

Standard pathology tests outperform molecular subtyping in bladder cancer

byMedical College of Georgia at Augusta UniversityDr. Vinata B. Lokeshwar and graduate students Sarrah S. Lahorewala and Daley S. Morera. Credit: Phil Jones, Senior Photographer, Augusta Univers

Updated on:December 23,2023